Tillotts Pharma AG

Tillotts Pharma AG is a dynamic and rapidly expanding specialty pharmaceutical company, part of the esteemed Japanese Zeria Group. With a dedicated team of nearly 400 professionals across Switzerland and internationally, Tillotts Pharma AG excels in the development, acquisition, and commercialization of cutting-edge pharmaceutical products focused on the digestive system.

Tillotts Pharma AG successfully markets its proprietary treatments for conditions such as Inflammatory Bowel Disease (IBD) and Clostridioides difficile infection (CDI), alongside a portfolio of in-licensed products. These are distributed across approximately 65 countries, leveraging a robust network of European affiliates and global partners. The primary address of Tillotts Pharma AG is Baslerstrasse 15, Rheinfelden, 4310, CH.

Dedicated to ethical business practices and continuous improvement, Tillotts Pharma AG embodies values of passion, performance, progress, accountability, collaboration, and integrity. Tillotts Pharma AG is poised for continued growth and success in the pharmaceutical sector. We invite the manager of Tillotts Pharma AG to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.